This study investigates metastatic pancreatic ductal adenocarcinoma. The purpose of this study is to explore the effects of alternating chemotherapy regimens.
The study evaluates the effectiveness and safety of the chemotherapy treatments. It focuses on understanding how these treatments work in managing the condition.
- Who can participate: Adults over 18 with metastatic pancreatic cancer can join. Participants must have measurable disease and meet specific health criteria.
- Study details: Participants will receive alternating chemotherapy regimens.